Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 3404 for cancer

Edit search filters
  1. Gingseng for Cancer Related Fatigue

    Rochester, MN, Albert Lea, MN, Mankato, MN

  2. A Collaborative Intervention for Improving Cancer Pain Management in Rural and Hispanic Cancer Survivors (ASCENT)

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. FrαDcs or Placebo for Patients With Advanced Stage Ovarian Cancer

    Jacksonville, FL, Rochester, MN, Scottsdale/Phoenix, AZ

  4. Colorectal Cancer Screening/Microbiome Collection

    Jacksonville, FL

  5. Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer (FRAPPE)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Phase 2 Study of VGT-309 in Lung Cancer

    Rochester, MN

  7. Virtual Mindfulness and Weight Management Program in Patients with Cancer Histories

    La Crosse, WI

  8. Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Study of Sacituzumab Govitecan (IMMU-132) in Metastatic or Locally Advanced Unresectable Urothelial Cancer

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer